Madurai G Ganesan

Title: The Innovative Contributions of Madurai G Ganesan

Introduction

Madurai G Ganesan is a notable inventor based in Suffern, NY (US). He has made significant contributions to the field of pharmaceutical delivery systems, holding a total of 7 patents. His work focuses on improving the efficacy and delivery of medications, particularly minocycline.

Latest Patents

One of his latest patents involves pulsatile once-a-day delivery systems for minocycline. This innovative pharmaceutical delivery system includes 7-dimethyl-6-deoxy-6-demethyltetracycline or a non-toxic acid addition salt. The system comprises mixtures or separate administration units of pH-sensitive polymer-coated spherical granules. These granules are designed to release minocycline in a medium with a pH ranging from about 4.0 to about 7.5. Additionally, it includes coated or uncoated quick-release granules that release minocycline in a medium with a pH of less than about 3.9 or minocycline powder. The formulations provide at least minimum therapeutic blood levels of minocycline for at least about 24 hours when administered only once a day. Methods for the preparation of these systems and formulations are also included in his patents.

Career Highlights

Madurai G Ganesan is associated with American Cyanamid Company, where he has contributed to various innovative projects. His expertise in pharmaceutical sciences has led to advancements in drug delivery systems, enhancing patient care and treatment outcomes.

Collaborations

He has collaborated with notable coworkers, including Nitin V Sheth and Joseph J Valorose, Jr. These collaborations have fostered a creative environment that encourages innovation and the development of new technologies in the pharmaceutical field.

Conclusion

Madurai G Ganesan's contributions to pharmaceutical delivery systems exemplify the impact of innovation in healthcare. His work continues to influence the way medications are delivered, ensuring better therapeutic outcomes for patients.